Combinations of antithrombotic therapies prescribed after percutaneous coronary intervention in patients with acute coronary syndromes and atrial fibrillation: data from the nationwide MATADOR-PCI registry

Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e45-e47. doi: 10.1093/ehjcvp/pvaa088.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Coronary Syndrome* / diagnosis
  • Acute Coronary Syndrome* / drug therapy
  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / drug therapy
  • Atrial Fibrillation* / epidemiology
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Registries

Substances

  • Fibrinolytic Agents

Associated data

  • ClinicalTrials.gov/NCT03656523